A two-drug combination frequently used in anti-aging research causes brain damage in mice, report University of Connecticut researchers in the Proceedings of the National Academy of Sciences. The findings, titled “Senolytic treatment induces oligodendrocyte dysfunction and demyelination in the corpus callosum,” should make doctors cautious about prescribing the drug combo prophylactically, but also suggest new ways to understand multiple sclerosis.
This article was originally published on MedicalXpress.com
